Co-crystal of tramadol–celecoxib (CTC) for acute moderate-to-severe pain

Objective This narrative review aims to provide a clinical perspective on the potential role of co-crystal of tramadol–celecoxib (CTC) in the management of acute moderate-to-severe pain by synthesizing the available preclinical and clinical data, with emphasis on phase 3 trials.